Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence (2020)
- Authors:
- Autor USP: SOARES, IRENE DA SILVA - FCF
- Unidade: FCF
- DOI: 10.1128/AAC.02056-19
- Subjects: PLASMODIUM; MALÁRIA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Publisher place: Washington
- Date published: 2020
- Source:
- Título do periódico: Antimicrobial Agents and Chemotherapy
- ISSN: 1098-6596
- Volume/Número/Paginação/Ano: v. 64, n. 5, p. 1-14 art. e02056-19, 2020
- Este periódico é de assinatura
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: green
-
ABNT
SILVINO, Ana Carolina Rios et al. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, v. 64, n. 5, p. 1-14 art. e02056-19, 2020Tradução . . Disponível em: https://doi.org/10.1128/AAC.02056-19. Acesso em: 19 abr. 2024. -
APA
Silvino, A. C. R., Kano, F. S., Costa, M. A., Fontes, C. J. F., Soares, I. da S., Brito, C. F. A. de, et al. (2020). Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence. Antimicrobial Agents and Chemotherapy, 64( 5), 1-14 art. e02056-19. doi:10.1128/AAC.02056-19 -
NLM
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1128/AAC.02056-19 -
Vancouver
Silvino ACR, Kano FS, Costa MA, Fontes CJF, Soares I da S, Brito CFA de, Carvalho LH, Sousa TN de. Novel insights into Plasmodium vivax therapeutic failure: CYP2D6 activity and time of exposure to malaria modulate the risk of recurrence [Internet]. Antimicrobial Agents and Chemotherapy. 2020 ; 64( 5): 1-14 art. e02056-19.[citado 2024 abr. 19 ] Available from: https://doi.org/10.1128/AAC.02056-19 - The pan HLA DR-binding epitope improves adjuvant-assisted immunization with a recombinant protein containing a malaria vaccine candidate
- Interferon-G plays a critical role in CpG oligodeoxynucleotide-adjuvanted immunization with recombinant proteins
- Naturally acquired immunity to recombinant Plasmodium vivax apical membrane antigen-1 in individuals from Brazilian amazon region
- Antibody response of naturally infected individuals to recombinant Plasmodium vivax variant antigens (VIR)
- Blood-stage Plasmodium vivax antibody dynamics in a low transmission setting: a nine year follow-up study in the Amazon region
- Serologically defined heterogeneity in P. vivax malaria transmission using a novel chimeric recombinant protein in riverine villages of the Peruvian Amazon
- Plasmodium vivax circumsporozoite genotypes: a limited variation or new subspecies with major biological consequences?
- Geração de proteínas recombinantes baseadas nos subdomínios do antígeno 1 de membrana apical de Plasmodium vivax (PvAMA-1) e análise comparativa de suas propriedades antigênicas
- Resenha sem título próprio
- Identification of a highly antigenic linear B cell epitope within Plasmodium vivax apical membrane antigen 1 (AMA-1)
Informações sobre o DOI: 10.1128/AAC.02056-19 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
